Literature DB >> 32012318

Knockdown of circular RNA UBAP2 inhibits the malignant behaviours of esophageal squamous cell carcinoma by microRNA-422a/Rab10 axis.

Yu Wu1, Lingran Zhi2, Ying Zhao2, Lili Yang2, Fengmei Cai2.   

Abstract

Esophageal squamous cell carcinoma (ESCC) is a major type of esophageal cancer, accounting for about 90% of cases. Circular RNA UBAP2 (circUBAP2) is involved in the progression of several types of cancers. However, the role of circUBAP2 in ESCC remains unclear. In the present study, circUBAP2 expression was found to be upregulated in ESCC tumour tissues. Knockdown of circUBAP2 through infection with lentiviral vector encoding shRNA targeting circUBAP2 (sh-circUBAP2) inhibited the proliferation, migration and invasion of ESCC cells. In addition, circUBAP2 significantly promoted the proliferation, migration and invasion of ESCC cells. In vivo xenograft assay demonstrated that circUBAP2 downregulation suppressed the tumour growth of ESCC. Further mechanism investigations proved that circUBAP2 exerted its role via sponging microRNA (miR)-422a, and miR-422a directly targeted Rab10 in ESCC cells. These findings suggested that circUBAP2 acted as oncogene through regulating the miR-422a/Rab10 axis in ESCC.
© 2020 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Rab10; circUBAP2; esophageal squamous cell carcinoma (ESCC); miR-422a; oncogene

Year:  2020        PMID: 32012318     DOI: 10.1111/1440-1681.13269

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  13 in total

1.  Circular RNAs With Efficacy in Preclinical In Vitro and In Vivo Models of Esophageal Squamous Cell Carcinoma.

Authors:  Ulrich H Weidle; Tatjana Sela; Ulrich Brinkmann; Jens Niewoehner
Journal:  Cancer Genomics Proteomics       Date:  2022 May-Jun       Impact factor: 4.069

Review 2.  Biological roles and potential clinical values of circular RNAs in gastrointestinal malignancies.

Authors:  Xueping Tao; Yongfu Shao; Jianing Yan; Liyang Yang; Qihua Ye; Qingling Wang; Rongdan Lu; Junming Guo
Journal:  Cancer Biol Med       Date:  2021-03-12       Impact factor: 4.248

3.  Circular RNA UBAP2 promotes the proliferation of prostate cancer cells via the miR-1244/MAP3K2 axis.

Authors:  Xiaodong Li; Baihetiya Azhati; Wenguang Wang; Mulati Rexiati; Chen Xing; Yujie Wang
Journal:  Oncol Lett       Date:  2021-04-21       Impact factor: 2.967

4.  circUBAP2 regulates osteosarcoma progression via the miR‑204‑3p/HMGA2 axis.

Authors:  Weiguo Ma; Ning Xue; Junhua Zhang; Dan Wang; Xiaobin Yao; Lin Lin; Qingxia Xu
Journal:  Int J Oncol       Date:  2021-01-27       Impact factor: 5.650

Review 5.  Role of circular RNAs in gastrointestinal tumors and drug resistance.

Authors:  Shi-Jun Xi; Wen-Qi Cai; Qin-Qi Wang; Xiao-Chun Peng
Journal:  World J Clin Cases       Date:  2021-12-06       Impact factor: 1.337

6.  Decreased circUBAP2 Expression Is Associated with Preeclampsia by Limiting Trophoblast Cell Proliferation and Migration.

Authors:  Tingting Qi; Di Zhang; Xuting Shi; Minhui Li; Hongbin Xu
Journal:  Reprod Sci       Date:  2021-01-27       Impact factor: 3.060

7.  Emerging roles of circUBAP2 targeting miR-370-3p in proliferation, apoptosis, and invasion of papillary thyroid cancer cells.

Authors:  Hui Xiong; Jinsong Yu; Guangwei Jia; Yang Su; Jianliang Zhang; Qiu Xu; Xiaoxiong Sun
Journal:  Hum Cell       Date:  2021-08-03       Impact factor: 4.374

Review 8.  Circular RNA is a popular molecule in tumors of the digestive system (Review).

Authors:  Hao-Ying Wang; Yu-Ping Wang; Xi Zeng; Ya Zheng; Qing-Hong Guo; Rui Ji; Yong-Ning Zhou
Journal:  Int J Oncol       Date:  2020-04-27       Impact factor: 5.650

Review 9.  Circular RNAs in gastrointestinal cancer: Current knowledge, biomarkers and targeted therapy (Review).

Authors:  Xiaorui Zhao; Yue Wang; Qiongfang Yu; Pei Yu; Qiaoyu Zheng; Xue Yang; Dian Gao
Journal:  Int J Mol Med       Date:  2020-09-16       Impact factor: 4.101

10.  Oncogenic circDHTKD1 promotes tumor growth and metastasis of oral squamous cell carcinoma in vitro and in vivo via upregulating miR-326-mediated GAB1.

Authors:  Zhuangzhi Wu; Xiaoning He; Siqi Chen
Journal:  Braz J Med Biol Res       Date:  2021-07-16       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.